OTTAWA,
May 5, 2014 /CNW/ - Tweed Marijuana
Inc. (TSXV: TWD) is pleased to announce that its wholly owned
subsidiary Tweed Inc. ("Tweed") has shipped its first orders of
medical marijuana to customers. The product, which has been
produced in Tweed's Smiths Falls facility from "seed to sale", has
been tested by Tweed to be in
conformance with the Health Canada Marihuana for Medical
Purposes Regulations (MMPR).
"We are very happy that Tweed's medicine is en route to those who need
it," said Tweed CEO and Co-founder Chuck
Rifici. "The team at Tweed
is committed to making more and more strains available as quickly
as possible."
Registered customers may now visit Tweed's online store to purchase their medical
marijuana.
About Tweed Marijuana Inc.
Tweed Marijuana Inc. (TSXV: TWD) is a TSX Venture Exchange listed
company. Its wholly owned subsidiary, Tweed, is a licensed
producer of medical marijuana in Canada. The principal activities of
Tweed are the production and sale
of marijuana out of its facility in Smiths Falls, Ontario as regulated by
the Marihuana for Medical Purposes Regulations. To
learn more about Tweed, visit
www.tweed.com.
Neither TSX Venture Exchange nor its
Regulation Services Provider (as that term is defined in the
policies of the TSX Venture Exchange) accepts responsibility for
the adequacy or accuracy of this release.
SOURCE Tweed Marijuana Inc.